{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:30:46Z","timestamp":1792593046927,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jconrel.2024.05.023","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:19:57Z","timestamp":1715977197000},"page":"798-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing"],"prefix":"10.1016","volume":"370","author":[{"given":"Dasom","family":"Mun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.05.023_bb0005","first-page":"e6","article-title":"Heart disease and stroke statistics\u20142013 update","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0015","first-page":"e85","article-title":"Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0020","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.biocel.2006.04.010","article-title":"Acute myocardial infarction and heart failure: role of apoptosis","volume":"38","author":"Abbate","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0025","first-page":"158","article-title":"Aging and cardiac fibrosis","volume":"2","author":"Biernacka","year":"2011","journal-title":"Aging Dis."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165768","article-title":"Mitochondrial ROS in myocardial ischemia reperfusion and remodeling","volume":"1866","author":"Bugger","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00395-020-0775-5","article-title":"TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation","volume":"115","author":"Adapala","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJMe2034624","article-title":"Treatment by CRISPR-Cas9 gene editing - a proof of principle","volume":"384","author":"Malech","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.973326","article-title":"Delivering the CRISPR\/Cas9 system for engineering gene therapies: recent cargo and delivery approaches for clinical translation","volume":"10","author":"Foley","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mattod.2018.12.003","article-title":"Material solutions for delivery of CRISPR\/Cas-based genome editing tools: current status and future outlook","volume":"26","author":"Wan","year":"2019","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3349\/ymj.2022.63.2.105","article-title":"Basic principles and clinical applications of CRISPR-based genome editing","volume":"63","author":"Lim","year":"2022","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0065","doi-asserted-by":"crossref","unstructured":"J.D. Gillmore, E. Gane, J. Taubel, J. Kao, M. Fontana, M.L. Maitland, J. Seitzer, D. O'Connell, K.R. Walsh, K. Wood, J. Phillips, Y. Xu, A. Amaral, A.P. Boyd, J.E. Cehelsky, M.D. McKee, A. Schiermeier, O. Harari, A. Murphy, C.A. Kyratsous, B. Zambrowicz, R. Soltys, D.E. Gutstein, J. Leonard, L. Sepp-Lorenzino, D. Lebwohl, CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis, N. Engl. J. Med., 385 493\u2013502.","DOI":"10.1056\/NEJMoa2107454"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6040105","article-title":"CRISPR\/Cas9 for Cancer therapy: hopes and challenges","volume":"6","author":"Martinez-Lage","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0075","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1039\/D0TB01925A","article-title":"Coassembly of nucleus-targeting gold nanoclusters with CRISPR\/Cas9 for simultaneous bioimaging and therapeutic genome editing","volume":"9","author":"Tao","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0085","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158163","article-title":"Extracellular vesicles in blood: sources, effects, and applications","volume":"22","author":"Alberro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12076","article-title":"Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing","volume":"10","author":"Yao","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673286","article-title":"Nanoparticle delivery of CRISPR\/Cas9 for genome editing","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-020-0389-5","article-title":"Native and bioengineered extracellular vesicles for cardiovascular therapeutics","volume":"17","author":"de Abreu","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0125","first-page":"240","article-title":"Engineered exosomes for future gene-editing therapy","volume":"3","author":"Guo","year":"2022","journal-title":"Biomater Transl"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0130","doi-asserted-by":"crossref","unstructured":"T. Wan, J. Zhong, Q. Pan, T. Zhou, Y. Ping, X. Liu, Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tiss ue-specific gene therapy of liver diseases, Sci. Adv., 8 eabp9435.","DOI":"10.1126\/sciadv.abp9435"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0135","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1093\/nar\/gkaa683","article-title":"Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR\/Cas9 system for gene therapy","volume":"48","author":"Zhuang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100026","article-title":"Subtype-directed differentiation of human iPSCs into atrial and ventricular cardiomyocytes","volume":"1","author":"Kleinsorge","year":"2020","journal-title":"STAR Protocols"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0145","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-0716-1386-3_13","article-title":"CRISPR\/Cas9 system to knockdown MicroRNA in vitro and in vivo","volume":"2300","author":"Yi","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0160","doi-asserted-by":"crossref","first-page":"17615","DOI":"10.1073\/pnas.1206432109","article-title":"Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function","volume":"109","author":"Bernardo","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0170","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1007\/s00018-021-03979-4","article-title":"MicroRNA-34a: the bad guy in age-related vascular diseases","volume":"78","author":"Raucci","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0175","doi-asserted-by":"crossref","unstructured":"K. Iekushi, F. Seeger, B. Assmus, A.M. Zeiher, S. Dimmeler, Regulation of Cardiac microRNAs by Bone Marrow Mononuclear Cell Therap Y in Myocardial Infarction, Circulation, 125 1765-1773, S1761-1767.","DOI":"10.1161\/CIRCULATIONAHA.111.079699"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0180","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCRESAHA.117.305962","article-title":"MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction","volume":"117","author":"Yang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101692","article-title":"Genome editing technology: a new frontier for the treatment and prevention of cardiovascular diseases","volume":"48","author":"Saeed","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","article-title":"Targeted delivery of therapeutic agents to the heart","volume":"18","author":"Sahoo","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040147","article-title":"Cardiac targeting peptide, a novel cardiac vector: studies in bio-distribution, imaging application, and mechanism of transduction","volume":"8","author":"Zahid","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","article-title":"Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes","volume":"499","author":"Kim","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0205","doi-asserted-by":"crossref","unstructured":"J.-Y. Kang, D. Mun, Y. Chun, D.-S. Park, H. Kim, N. Yun, B. Joung, Engineered small extracellular vesicle-mediated NOX4 siRNA delivery fo r targeted therapy of cardiac hypertrophy, Journal of extracellular vesicles, 12 e12371.","DOI":"10.1002\/jev2.12371"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1126\/science.1109778","article-title":"The convergence of synthetic organic and polymer chemistries","volume":"309","author":"Hawker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0215","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","article-title":"Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012252","article-title":"Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice","volume":"5","author":"Zahid","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040147","article-title":"Cardiac targeting peptide, a novel cardiac vector: studies in bio-distribution, imaging application, and mechanism of transduction","volume":"8","author":"Zahid","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0235","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"L\u00f6tvall","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jconrel.2024.05.023_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113238","article-title":"Oxidative stress \u2013 complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders","volume":"152","author":"Rotariu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0245","doi-asserted-by":"crossref","first-page":"1656450","DOI":"10.1155\/2016\/1656450","article-title":"The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited","volume":"2016","author":"Kurian","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2024.05.023_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: the nanoparticle and submicron Nanocompounds gateway into the cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T03:11:10Z","timestamp":1740193870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":50,"alternative-id":["S0168365924003079"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}